Cargando…

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Detalles Bibliográficos
Autores principales:	August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117134/ https://www.ncbi.nlm.nih.gov/pubmed/35449420 http://dx.doi.org/10.1038/s41591-022-01817-z

Ejemplares similares

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
por: August, Allison, et al.
Publicado: (2021)

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
por: Narayanan, Elisabeth, et al.
Publicado: (2022)

2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3
por: Shaw, Christine, et al.
Publicado: (2019)

A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2012)

ERRATUM: A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
por: Vu, David M., et al.
Publicado: (2013)

Role of antibodies in cancer targeting
por: Attarwala, Husain
Publicado: (2010)

Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus
por: Jin, Jing, et al.
Publicado: (2019)

Structural basis of Chikungunya virus inhibition by monoclonal antibodies
por: Zhou, Qun Fei, et al.
Publicado: (2020)

Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age
por: Kumar, Vipul, et al.
Publicado: (2019)

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques
por: Broeckel, Rebecca, et al.
Publicado: (2017)

Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
por: August, Allison, et al.
Publicado: (2022)

Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
por: Pal, Pankaj, et al.
Publicado: (2013)

mRNA-1273 Vaccine-elicited Neutralization of SARS-CoV-2 Omicron in Adolescents and Children
por: Girard, Bethany, et al.
Publicado: (2022)

Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
por: Costa, Isabella, et al.
Publicado: (2014)

Translational Pharmacokinetic/Pharmacodynamic Model for mRNA-3927, an Investigational Therapeutic for the Treatment of Propionic Acidemia
por: Attarwala, Husain, et al.
Publicado: (2023)

Comparing the Similarity of Different Groups of Bacteria to the Human Proteome
por: Trost, Brett, et al.
Publicado: (2012)

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa
por: Pajon, Rolando, et al.
Publicado: (2013)

In-Situ Simulation Enhances Emergency Preparedness in Pediatric Care Practices
por: Kalidindi, Shiva, et al.
Publicado: (2018)

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2017)

Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021)

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
por: Hard, Marjie L., et al.
Publicado: (2018)

A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens
por: Konar, Monica, et al.
Publicado: (2015)

A Neutralizing Monoclonal Antibody Targeting the Acid-Sensitive Region in Chikungunya Virus E2 Protects from Disease
por: Selvarajah, Suganya, et al.
Publicado: (2013)

In vitro and in vivo efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered Nicotiana benthamiana plants
por: Hurtado, Jonathan, et al.
Publicado: (2019)

Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins
por: Quiroz, Jose A., et al.
Publicado: (2019)

Etymologia: chikungunya
Publicado: (2006)

Congenital Chikungunya
por: Gopakumar, Hariharan, et al.
Publicado: (2012)

Chikungunya: epidemiology
por: Petersen, Lyle R., et al.
Publicado: (2016)

Chikungunya Virus
por: Vu, David M., et al.
Publicado: (2017)

Neonate with chikungunya
por: Gupta, Vishal, et al.
Publicado: (2021)

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia
por: Hard, Marjie L., et al.
Publicado: (2018)

TGN1412: From Discovery to Disaster
por: Attarwala, H
Publicado: (2010)

Fluorescent and electrochemical dual-mode detection of Chikungunya virus E1 protein using fluorophore-embedded and redox probe-encapsulated liposomes
por: Nasrin, Fahmida, et al.
Publicado: (2020)

Promising application of monoclonal antibody against chikungunya virus E1-antigen across genotypes in immunochromatographic rapid diagnostic tests
por: Suzuki, Keita, et al.
Publicado: (2020)

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal(®) Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
por: Hard, Marjie L., et al.
Publicado: (2019)

Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
por: Weiden, Peter J., et al.
Publicado: (2020)

Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) Amyloidosis
por: Zhang, Xiaoping, et al.
Publicado: (2019)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
por: Hard, Marjie L., et al.
Publicado: (2017)

Chikungunya Infection in Travelers
por: Hochedez, Patrick, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lglm8lmdo5nmu6ba301vepk184